Burroughs Wellcome's Nuromax (doxacurium chloride)
Executive Summary
Injectable neuromuscular blocking agent will be discussed at the Jan. 24 meeting of FDA's Anesthetic and Life Support Drugs Advisory Committee. The meeting begins at 8:30 a.m. in conference rooms D & E of FDA's Parklawn building.